Host-directed therapies against tuberculosis

Lancet Respir Med. 2014 Feb;2(2):85-7. doi: 10.1016/S2213-2600(13)70295-9. Epub 2014 Jan 9.

Author

Robert John Wilkinson¹

Affiliation

¹ Division of Medicine, Imperial College London, London, UK; Clinical Infectious Disease Research Initiative, Room 3.03.05 Wolfson Pavilion, Institute of Infectious Disease and Molecular Medicine, University of Cape Town Observatory 7925, South Africa; Medical Research Council National Institute for Medical Research, London, UK. Electronic address: r.j.wilkinson@imperial.ac.uk.

PMID: 24503259
DOI: 10.1016/S2213-2600(13)70295-9

No abstract available

Publication types

Comment

MeSH terms

Antitubercular Agents / therapeutic use*
Female
Humans
Male
Mesenchymal Stem Cell Transplantation*
Mycobacterium tuberculosis / drug effects*
Tuberculosis, Multidrug-Resistant / surgery*
Tuberculosis, Pulmonary / surgery*
Tuberculosis, Pulmonary / therapy*

Substances

Antitubercular Agents

Grants and funding